Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers

Fig. 2

Serum CA125 and ascites IL-6 levels can discriminate between patients with serous EOC or benign gynecological conditions. The markers with cutoff (pg/ml for IL-6 and kUI/L for CA125) are depicted together with the percentage of the patients with EOC or benign conditions that were predicted by the combination of markers

Back to article page